TeKBrace Knotless Anchor
TheraMicro · Decision date Oct 21, 2026
What did the FDA decide?
The FDA recorded a substantial equivalence determination, decision code SESE, on October 21, 2026 for TeKBrace Knotless Anchor, submitted by TheraMicro of Cordova, Tennessee under premarket notification K263352. The device falls in the orthopedic specialty under product code MBI. The available record identifies the submission as a section 510(k) premarket notification; it does not describe the device's components, materials, sizes or design features beyond the product name.
The decision letter states that the device is substantially equivalent, for the indications for use stated in the enclosure, to legally marketed predicate devices. Substantial equivalence under section 510(k) is a clearance to market, not premarket approval. The enclosure carrying the indications for use is not included in the retrieved excerpt, and the record shows no supplement type or reason, so no cleared labeling, predicate identity or clinical data can be reported here.
The source data do not state the predicate device or devices, the indications for use, or any conditions of clearance. Readers should treat the clearance date and decision code as the confirmed facts and consult the full FDA document for labeling scope.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 21, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263352
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- TheraMicro
- Product code
- MBI
- Decision code
- SESE
- Decision date
- Oct 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Fastener, Fixation, Nondegradable, Soft Tissue.
- Applicant
- TheraMicro
- Product code
- MBI
- FDA device class
- 2
FDA decision timeline
K263352 received
Application receipt date recorded by FDA.
K263352 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MBI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Arthrex FiberButtonK263477 | ARTHREX, INC. | 510(k) clearance | Oct 27, 2026 | FDA |
| Smith & Nephew, Inc. | 510(k) clearance | Oct 23, 2026 | FDA | |
| Anika Therapeutics, Inc. | 510(k) clearance | Sep 17, 2026 | FDA | |
| Aevumed, Inc. | 510(k) clearance | Sep 2, 2026 | FDA | |
ArthroTAK Tendon Anchor KitK262809 | ArthroTAK, LLC | 510(k) clearance | Sep 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
TheraMicro
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Cordova, TN
Sources and methodology
- Original FDA record: K263352
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



